SMARTPHONE-BASED OBJECTIVE OUTCOME MEASURES IN CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY: A SYSTEMATIC REVIEW OF VALIDITY AND CLINICAL UTILITY

Main Article Content

Dr. Tanigaiselvane D.J
Dr. Muthukumaran Calyanasundaram
Dr. Mohan Nallathambi PT
Dr. Neethi
Dr Sharmila.B
Mrs. Jeyanthi

Keywords

chemotherapy-induced peripheral neuropathy, smartphone, digital health, mHealth, accelerometer, photoplethysmography, balance, heart rate variability, outcome assessment

Abstract

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating sequela of cancer treatment, traditionally assessed through subjective patient-reported outcomes (PROs) and clinical examinations. These methods are susceptible to bias and may lack sensitivity. Smartphone sensor technology offers a promising alternative for objective, quantifiable, and accessible monitoring of CIPN symptoms, particularly balance and autonomic dysfunction.


Objective: This systematic review aimed to critically evaluate the validity, reliability, and clinical utility of smartphone-based objective outcome measures for assessing balance and autonomic function in patients with CIPN.


Methods: A systematic search was conducted in PubMed, Scopus, CINAHL, IEEE Xplore, and Cochrane Library databases from inception to December 2018. Studies were included if they evaluated the use of smartphone sensors (accelerometers, gyroscopes, cameras) to assess balance, gait, or heart rate variability (HRV) in adults with CIPN or related peripheral neuropathies. Risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool.


Results: Out of 327 records identified, five studies met the inclusion criteria. No studies were found that validated smartphone sensors exclusively in a CIPN population; thus, studies in diabetic peripheral neuropathy (DPN) and other neuropathies were included. The reviewed studies demonstrated strong concurrent validity of smartphone accelerometry for measuring postural sway against laboratory-grade force plates (correlation coefficients r = 0.82–0.94). Smartphone photoplethysmography (PPG) for HRV assessment showed excellent agreement with electrocardiography (ECG) for time-domain parameters (RMSSD ICC > 0.85) in controlled, resting conditions. Evidence for reliability and validity in home-based settings was limited.


Conclusion: Pre-2018 evidence, primarily from non-CIPN neuropathies, strongly supports the criterion validity of smartphone-based accelerometry for balance assessment and PPG for HRV measurement in controlled environments. However, a significant evidence gap exists regarding the application and validation of these digital biomarkers specifically in CIPN populations. Future research must validate these tools in CIPN cohorts and explore their feasibility for remote monitoring and integration into clinical practice to improve assessment precision and patient outcomes.

Abstract 40 | Pdf Downloads 28

References

1. Argyriou, A. A., Bruna, J., Marmiroli, P., & Cavaletti, G. (2012). Chemotherapy-induced peripheral neurotoxicity (CIPN): An update. *Critical Reviews in Oncology/Hematology, 82*(1), 51–77. https://doi.org/10.1016/j.critrevonc.2011.04.012
2. Bessette, L., Sangha, A., & Kuntz, S. (2018). Technology-assisted rehabilitation following total knee or hip replacement for people with osteoarthritis: A systematic review and meta-analysis. BMC Musculoskeletal Disorders, 19(1), 380. https://doi.org/10.1186/s12891-018-2300-7
3. Bolkhovsky, J. B., Scully, C. G., & Chon, K. H. (2012). Statistical analysis of heart rate and heart rate variability monitoring through the use of smart phone cameras. 2012 Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 1610–1613. https://doi.org/10.1109/EMBC.2012.6346247
4. Bonato, P. (2010). Wearable sensors and systems. IEEE Engineering in Medicine and Biology Magazine, 29(3), 25–36. https://doi.org/10.1109/MEMB.2010.936554
5. Cavaletti, G., Frigeni, B., Lanzani, F., Mattavelli, L., Susani, E., Alberti, P., ... & Bidoli, P. (2010). Chemotherapy-induced peripheral neurotoxicity assessment: A critical revision of the currently available tools. European Journal of Cancer, 46(3), 479–494. https://doi.org/10.1016 /j.ejca.2009.12.008
6. Galán-Mercant, A., & Cuesta-Vargas, A. I. (2014). Differences in trunk accelerometry between frail and non-frail elderly persons in functional tasks. BMC Research Notes, 7, 100. https://doi.org/10.1186/1756-0500-7-100
7. Hillebrand, A., & Clarenbach, P. (2018). Smartphone Applications in Movement Disorders. Movement Disorders Clinical Practice, 5(2), 125–127. https://doi.org/10.1002 /mdc3.12576
8. Kneis, S., Wehrle, A., Dalin, D., Wiesmeier, I. K., & Maurer, C. (2016). It's never too late - Balance and endurance training improves functional performance, quality of life, and alleviates neuropathic symptoms in cancer survivors suffering from chemotherapy-induced peripheral neuropathy: Results of a randomized controlled trial. BMC Cancer, 16, 787. https://doi.org/10.1 186/s12885-016-2810-3
9. Kolb, N. A., Smith, A. G., Singleton, J. R., Beck, S. L., Stoddard, G. J., Brown, S., & Mooney, K. (2016). The association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling. JAMA Neurology, 73(7), 860–866. https://doi.org/10.1001/jamaneurol.2016.0383
10. Lustberg, M. B., & Nurgali, K. (2018). Emerging therapies and future directions for the management of chemotherapy-induced peripheral neuropathy. Current Opinion in Physiology, 4, 17–22. https://doi.org/10.1016/j.cophys.2018.04.001
11. Mancini, M., Horak, F. B., Zampieri, C., Carlson-Kuhta, P., Nutt, J. G., & Chiari, L. (2012). Trunk accelerometry reveals postural instability in untreated Parkinson's disease. Parkinsonism & Related Disorders, 18(5), 557–562. https://doi.org/10.1016/j.parkreldis.2012.02.004
12. O’Connor, M. L., & Edwards, J. D. (2018). The application of technology to improve assessment and intervention in cognitive rehabilitation. Current Opinion in Neurology, 31(6), 656–663. https://doi.org/10.1097/WCO.0000000000000615
13. Patel, S., Park, H., Bonato, P., Chan, L., & Rodgers, M. (2012). A review of wearable sensors and systems with application in rehabilitation. Journal of Neuroengineering and Rehabilitation, 9, 21. https://doi.org/10.1186/1743-0003-9-21
14. Piga, M., Cangemi, I., & Mathieu, A. (2017). Telemedicine for patients with rheumatic diseases: A systematic review. Rheumatology (Oxford), 56(1), 39–53. https://doi.org/10.1093/ rheumatology/kew342
15. Plews, D. J., Scott, B., Altini, M., Wood, M., Kilding, A. E., & Laursen, P. B. (2017). Comparison of heart-rate-variability recording with smartphone photoplethysmography, Polar H7 chest strap, and electrocardiography. International Journal of Sports Physiology and Performance, 12(10), 1324–1328. https://doi.org/10.1123/ijspp.2016-0668
16. Safaie, J., Grewal, G. S., & Najafi, B. (2015). Assessing balance control and fall risk using wearable sensors. Current Geriatrics Reports, 4(4), 343–352. https://doi.org/10.1007/s13670-015-0148-3
17. Schwenk, M., Hauer, K., Zieschang, T., Englert, S., Mohler, J., & Najafi, B. (2016). Sensor-derived physical activity parameters can predict future falls in people with dementia. Gerontology, 62(1), 99–107. https://doi.org/10.1159/000433533
18. Seretny, M., Currie, G. L., Sena, E. S., Ramnarine, S., Grant, R., MacLeod, M. R., ... & Fallon, M. T. (2014). Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain, 155(12), 2461–2470. https://doi.org /10.1016/j.pain.2014.09.020
19. Shah, V. V., McNames, J., Harker, G., Mancini, M., Carlson-Kuhta, P., Nutt, J. G., ... & Horak, F. B. (2018). Effect of age on the performance of the instrumented timed up and go test: A systematic review. Journal of NeuroEngineering and Rehabilitation, 15(1), 112. https://doi.org/10.1186 /s12984-018-0462-z
20. Sheshadri, V., & Metcalf, N. K. (2018). The role of wearable technology in the assessment of patients with peripheral artery disease: A systematic review. European Journal of Vascular and Endovascular Surgery, 56(4), 579–590. https://doi.org/10.1016/j.ejvs.2018.06.038
21. Winters-Stone, K. M., Horak, F., Jacobs, P. G., Trubowitz, P., Dieckmann, N. F., Stoyles, S., & Faithfull, S. (2017). Falls, functioning, and disability among women with persistent symptoms of chemotherapy-induced peripheral neuropathy. Journal of Clinical Oncology, 35(23), 2604–2612. https://doi.org/10.1200/JCO.2016.71.3552

Most read articles by the same author(s)